Kraig Biocraft Laboratories completes Final Facilities Review for First Batch of Recombinant Spider Silk Production in Vietnam

ANN ARBOR, Mich., – January 3, 2018 –Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announces today that key members of its management and production team have laid the groundwork for the Company’s Vietnamese spider silk production initiative. 

Working through an MOU, announced in November, the Company is collaborating with the Institute of Biotechnology – Vietnam Academy of Science and Technology (“IBT”) and Vietnam Sericulture Research Centre (“VSRC”) to rear and test the first ever recombinant spider silk silkworms in Vietnam.  The Kraig Labs team, in partnership with its subsidiary, Prodigy Textiles Co Ltd., held a series of meetings with senior members of the IBT and the VSRC to outline the project requirements and to review the facilities selected to raise the first batch of transgenic silkworms. 

The Kraig Labs team visited the IBT headquarters and brand new satellite location, where the team members reviewed IBT’s laboratory capabilities and discussed possible future collaborative research efforts. 

The team also spent time at the VSRC headquarters reviewing their rearing processes, discussing the details of the Company’s transgenic silkworms, and outlining requirements for hatching the Company’s silkworms.

The Company’s technology is designed to work hand-in-glove with existing silk production infrastructure, of which and is why the Company focused its efforts in Vietnam because of the existing infrastructure and history of silk manufacturing, which would theoretically allow for very rapid expansion of production.  With everything in place, Kraig Labs’ team believes that the Company is the verge of a major breakthrough in the commercialization of spider silk. 

“The silk experts of the VSRC, working in partnership with members of our Prodigy Textiles team, will give our expansion in Vietnam a strong foundation,” said COO Jon Rice.  “That expertise, combined with IBT’s facilities and capabilities, should pave the way to success, for this first of its kind effort, and translate into a smooth production scale up.”

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to   

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (, a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

This entry was posted on by .